ICON Gross Margin 2010-2024 | ICLR
Current and historical gross margin for ICON (ICLR) over the last 10 years. The current gross profit margin for ICON as of September 30, 2024 is %.
| ICON Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $8.31B | $2.46B | 29.59% |
| 2024-06-30 | $8.33B | $2.47B | 29.68% |
| 2024-03-31 | $8.23B | $2.44B | 29.61% |
| 2023-12-31 | $8.12B | $2.40B | 29.57% |
| 2023-09-30 | $8.02B | $2.36B | 29.45% |
| 2023-06-30 | $7.90B | $2.32B | 29.38% |
| 2023-03-31 | $7.82B | $2.27B | 29.09% |
| 2022-12-31 | $7.74B | $2.21B | 28.60% |
| 2022-09-30 | $7.66B | $2.16B | 28.20% |
| 2022-06-30 | $7.59B | $2.10B | 27.70% |
| 2022-03-31 | $6.52B | $1.80B | 27.58% |
| 2021-12-31 | $5.48B | $1.51B | 27.52% |
| 2021-09-30 | $4.36B | $1.21B | 27.67% |
| 2021-06-30 | $3.19B | $0.91B | 28.36% |
| 2021-03-31 | $2.94B | $0.84B | 28.54% |
| 2020-12-31 | $2.80B | $0.82B | 29.21% |
| 2020-09-30 | $2.76B | $0.81B | 29.29% |
| 2020-06-30 | $2.77B | $0.81B | 29.31% |
| 2020-03-31 | $2.85B | $0.84B | 29.60% |
| 2019-12-31 | $2.81B | $0.83B | 29.63% |
| 2019-09-30 | $2.76B | $0.81B | 29.50% |
| 2019-06-30 | $2.70B | $0.80B | 29.55% |
| 2019-03-31 | $2.65B | $0.79B | 29.69% |
| 2018-12-31 | $2.60B | $0.78B | 29.97% |
| 2018-09-30 | $2.37B | $0.77B | 32.29% |
| 2018-06-30 | $2.16B | $0.75B | 34.82% |
| 2018-03-31 | $1.95B | $0.74B | 38.03% |
| 2017-12-31 | $1.76B | $0.73B | 41.58% |
| 2017-09-30 | $1.74B | $0.73B | 41.83% |
| 2017-06-30 | $1.72B | $0.72B | 42.08% |
| 2017-03-31 | $1.70B | $0.72B | 42.11% |
| 2016-12-31 | $1.67B | $0.71B | 42.35% |
| 2016-09-30 | $1.64B | $0.70B | 42.57% |
| 2016-06-30 | $1.61B | $0.69B | 42.67% |
| 2016-03-31 | $1.59B | $0.68B | 42.70% |
| 2015-12-31 | $1.58B | $0.67B | 42.29% |
| 2015-09-30 | $1.56B | $0.65B | 41.74% |
| 2015-06-30 | $1.56B | $0.64B | 41.29% |
| 2015-03-31 | $1.54B | $0.63B | 40.66% |
| 2014-12-31 | $1.50B | $0.60B | 39.89% |
| 2014-09-30 | $1.46B | $0.57B | 39.07% |
| 2014-06-30 | $1.41B | $0.54B | 38.13% |
| 2014-03-31 | $1.37B | $0.51B | 37.18% |
| 2013-12-31 | $1.44B | $0.59B | 41.24% |
| 2013-09-30 | $1.39B | $0.57B | 40.99% |
| 2013-06-30 | $1.34B | $0.55B | 40.85% |
| 2013-03-31 | $1.28B | $0.52B | 40.87% |
| 2012-12-31 | $1.21B | $0.49B | 40.46% |
| 2012-09-30 | $1.15B | $0.46B | 40.38% |
| 2012-06-30 | $1.10B | $0.44B | 40.22% |
| 2012-03-31 | $1.06B | $0.43B | 40.47% |
| 2011-12-31 | $1.02B | $0.41B | 39.98% |
| 2011-09-30 | $1.01B | $0.42B | 41.21% |
| 2011-06-30 | $1.00B | $0.42B | 42.27% |
| 2011-03-31 | $0.99B | $0.43B | 43.77% |
| 2010-12-31 | $0.99B | $0.45B | 45.31% |
| 2010-09-30 | $0.99B | $0.45B | 45.94% |
| 2010-06-30 | $0.98B | $0.46B | 46.89% |
| 2010-03-31 | $0.98B | $0.46B | 47.29% |
| 2009-12-31 | $0.89B | $0.38B | 42.84% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $18.679B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| Cencora (COR) | United States | $46.107B | 17.62 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |